The FDA has approved a new triple-drug antibiotic from Merck & Co, but the company and regulator have cautioned it should only be prescribed for last-ditch use. Recarbrio – which based on established ...
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback